An Evidence-Based Update on Anticholinergic Use for Drug-Induced Movement Disorders
Authors (first, second and last of 12)
Collection
Digital Features - Neurology and Psychiatry
A collection of recent articles in the areas of neurology and psychiatry that are accompanied by digital features such as video abstracts, infographics and panel discussions published in Advances in Therapy, CNS Drugs and Neurology and Therapy.
Articles (43 in this collection)
-
-
-
Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient Records
Authors (first, second and last of 18)
-
The Development of Ofatumumab, a Fully Human Anti-CD20 Monoclonal Antibody for Practical Use in Relapsing Multiple Sclerosis Treatment
Authors (first, second and last of 16)
-
Summary of Research: Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis
Authors (first, second and last of 10)
-
-
Measuring Fatigue in Multiple Sclerosis: There may be Trouble Ahead
Authors (first, second and last of 4)
-
Summary of Research: Development and Validation of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ)
Authors (first, second and last of 5)
-
-
Comparative Effectiveness of Carbidopa/Levodopa Enteral Suspension and Deep Brain Stimulation on Pill Burden Reduction in Medicare Fee-for-Service Patients with Advanced Parkinson’s Disease
Authors (first, second and last of 12)
-
Optic Nerve Sheath Fenestration for Progressive Visual Loss in Cerebral Venous Sinus Thrombosis: A Long-Term Retrospective Observational Study
Authors (first, second and last of 13)
-
Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis
Authors (first, second and last of 7)
-
Persistence, Adherence, and Switching to Higher-Cost Therapy in Patients with Multiple Sclerosis Initiating Oral Disease-Modifying Therapies: A Retrospective Real-World Study
Authors (first, second and last of 5)
-
Potential Unmet Needs in Acute Treatment of Migraine in Japan: Results of the OVERCOME (Japan) Study
Authors (first, second and last of 8)
-
Dose Adjustment of Concomitant Antiseizure Medications During Cenobamate Treatment: Expert Opinion Consensus Recommendations
Authors (first, second and last of 7)
-
Benzodiazepines in the Management of Seizures and Status Epilepticus: A Review of Routes of Delivery, Pharmacokinetics, Efficacy, and Tolerability
Authors (first, second and last of 14)
-
Three Newly Recognized Likely Pathogenic Gene Variants Associated with Hereditary Transthyretin Amyloidosis
Authors (first, second and last of 8)
-
The Association Between the Occurrence of Common Treatment-Emergent Adverse Events and Efficacy Outcomes After Lasmiditan Treatment of a Single Migraine Attack: Secondary Analyses from Four Pooled Randomized Clinical Trials
Authors (first, second and last of 7)
-
A Targeted Literature Search and Phenomenological Review of Perspectives of People with Multiple Sclerosis and Healthcare Professionals of the Immunology of Disease-Modifying Therapies
Authors (first, second and last of 12)
-
Health-Related Quality of Life with Diroximel Fumarate in Patients with Relapsing Forms of Multiple Sclerosis: Findings from Qualitative Research Using Patient Interviews
Authors (first, second and last of 8)
-
Assessment and Management of Cognitive Function in Patients with Prostate Cancer Treated with Second-Generation Androgen Receptor Pathway Inhibitors
Authors (first, second and last of 5)
-
Efficacy and Safety Outcomes with Diroximel Fumarate After Switching from Prior Therapies or Continuing on DRF: Results from the Phase 3 EVOLVE-MS-1 Study
Authors (first, second and last of 17)
-
-
-
Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder
Authors (first, second and last of 10)
-
The Lived Experience of Myasthenia Gravis: A Patient-Led Analysis
Authors (first, second and last of 5)
-
AbobotulinumtoxinA Versus OnabotulinumtoxinA in Adults with Upper Limb Spasticity: A Randomized, Double-Blind, Crossover Study Protocol
Authors (first, second and last of 6)
-
-
Changes in Healthcare Resource Use and Costs in Commercially Insured Insomnia Patients Initiating Suvorexant
Authors (first, second and last of 7)
-
-
Clinical Perspectives on the Molecular and Pharmacological Attributes of Anti-CD20 Therapies for Multiple Sclerosis
Authors (first, second and last of 5)
-
Early Data on Long-term Impact of Inotersen on Quality-of-Life in Patients with Hereditary Transthyretin Amyloidosis Polyneuropathy: Open-Label Extension of NEURO-TTR
Authors (first, second and last of 10)
-
-
Exploring the Evidence for Broad-Spectrum Effectiveness of Perampanel: A Systematic Review of Clinical Data in Generalised Seizures
Authors (first, second and last of 8)
-
Hypervigilance, Allostatic Load, and Migraine Prevention: Antibodies to CGRP or Receptor
Authors (first, second and last of 6)
-
The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on ‘Off’-time in Patients with Advanced Parkinson’s Disease: A Systematic Review
Authors (first, second and last of 11)
-
Patient and Provider Insights into the Impact of Multiple Sclerosis on Mental Health: A Narrative Review
Authors (first, second and last of 5)
-
Comprehensive Approach to Management of Multiple Sclerosis: Addressing Invisible Symptoms—A Narrative Review
Authors (first, second and last of 5)
-
Multiple Sclerosis Patients Treated With Diroximel Fumarate in the Real-World Setting Have High Rates of Persistence and Adherence
Authors (first, second and last of 6)
-
Treatment Satisfaction of Galcanezumab in Japanese Patients with Episodic Migraine: A Phase 2 Randomized Controlled Study
Authors (first, second and last of 4)
-
Efficacy of Agomelatine 25–50 mg for the Treatment of Anxious Symptoms and Functional Impairment in Generalized Anxiety Disorder: A Meta-Analysis of Three Placebo-Controlled Studies
Authors (first, second and last of 5)
-
-
